Annual prevalence of systemic glucocorticoid (GC) prescription users in Denmark, 1999–2015, overall and stratified by sex and age group
| Prevalence of prescription users (% of the national population) | |||||||||||
| All | Sex | Age groups (years) | |||||||||
| Women | Men | 0–4 | 5–9 | 10–14 | 15–19 | 20–39 | 40–64 | 65–79 | 80+ | ||
| 1999 | 3.2 | 3.4 | 2.9 | 0.06 | 0.1 | 0.2 | 0.9 | 2.2 | 3.8 | 8.1 | 8.4 |
| 2000 | 3.3 | 3.6 | 3.0 | 0.06 | 0.1 | 0.2 | 1.0 | 2.4 | 3.9 | 8.1 | 8.7 |
| 2001 | 3.3 | 3.6 | 3.0 | 0.09 | 0.1 | 0.2 | 1.0 | 2.4 | 3.9 | 8.2 | 8.8 |
| 2002 | 3.3 | 3.6 | 3.0 | 0.06 | 0.1 | 0.3 | 1.1 | 2.6 | 3.9 | 8.1 | 8.9 |
| 2003 | 3.2 | 3.5 | 2.9 | 0.07 | 0.1 | 0.2 | 1.0 | 2.3 | 3.8 | 8.0 | 8.9 |
| 2004 | 3.2 | 3.5 | 2.9 | 0.06 | 0.1 | 0.2 | 0.9 | 2.3 | 3.8 | 8.0 | 8.9 |
| 2005 | 3.3 | 3.6 | 3.0 | 0.06 | 0.1 | 0.2 | 1.0 | 2.5 | 3.8 | 8.0 | 9.2 |
| 2006 | 3.4 | 3.7 | 3.0 | 0.07 | 0.1 | 0.3 | 1.1 | 2.5 | 4.0 | 8.0 | 9.3 |
| 2007 | 3.4 | 3.7 | 3.1 | 0.07 | 0.1 | 0.3 | 1.2 | 2.6 | 4.0 | 8.0 | 9.4 |
| 2008 | 3.4 | 3.7 | 3.1 | 0.07 | 0.1 | 0.3 | 1.2 | 2.6 | 3.9 | 7.7 | 9.5 |
| 2009 | 3.3 | 3.6 | 3.0 | 0.08 | 0.1 | 0.3 | 1.1 | 2.4 | 3.9 | 7.7 | 9.5 |
| 2010 | 3.3 | 3.6 | 2.9 | 0.07 | 0.1 | 0.2 | 1.0 | 2.2 | 3.8 | 7.6 | 9.7 |
| 2011 | 3.2 | 3.5 | 2.9 | 0.08 | 0.1 | 0.2 | 1.0 | 2.1 | 3.7 | 7.4 | 9.7 |
| 2012 | 3.1 | 3.4 | 2.8 | 0.07 | 0.1 | 0.2 | 0.9 | 2.0 | 3.6 | 7.2 | 9.7 |
| 2013 | 3.1 | 3.4 | 2.8 | 0.08 | 0.1 | 0.2 | 0.8 | 1.9 | 3.5 | 7.1 | 10 |
| 2014 | 3.1 | 3.4 | 2.8 | 0.07 | 0.1 | 0.2 | 0.8 | 1.9 | 3.5 | 7.0 | 9.8 |
| 2015 | 3.0 | 3.3 | 2.7 | 0.07 | 0.1 | 0.2 | 0.7 | 1.7 | 3.3 | 7.0 | 9.9 |
Reference group for all systemic GCs is all members of the Danish population as of 1 January in the year of interest. Reference groups for the stratified results are all members in the subpopulation of interest as of 1 January of each year.